What is Ceritinib?

Category: Prescription Drugs

Most popular types: Zykadia


Ceritinib is an orally administered product that may be used for the treatment of metastatic non-small cell lung cancer that has progressed after treatment with crizotinib (Xalkori®) and that is positive for anaplastic lymphoma kinase (ALK).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 2
Moderate 2
Mild 0
None 0

Commonly reported side effects and conditions associated with Ceritinib

Side effect Patients
Diarrhea 1
Nausea 1
Prolonged QT interval 1


Based on patients currently taking Ceritinib

Dosage Patients
750 mg daily 1

Why patients stopped taking Ceritinib

Multiple reasons could be selected

Reason Patients
Side effects too severe 1
See 1 patient who's stopped taking Ceritinib


Currently taking Ceritinib

Duration Patients
2 - 5 years 1

Stopped taking Ceritinib

Duration Patients
1 - 6 months 1
Adherence Evaluations
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 1
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 2
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 1
$25-49 1
< $25 0
Not specified 2

What people switch to and from

Patients started taking Ceritinib after stopping:

Treatment Patients
Crizotinib (Xalkori) 3
Bevacizumab (Avastin) 1
Chemotherapy 1
Last updated:
There are no evaluations for Ceritinib.